Detalhe da pesquisa
1.
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.
Ann Oncol
; 28(7): 1508-1516, 2017 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28472366
2.
New advances in genitourinary cancer: evidence gathered in 2014.
Cancer Metastasis Rev
; 34(3): 443-64, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26227584
3.
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study.
Ann Oncol
; 27(4): 706-11, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26658889
4.
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study.
Br J Cancer
; 109(1): 121-30, 2013 Jul 09.
Artigo
Inglês
| MEDLINE | ID: mdl-23799855
5.
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma.
Ann Oncol
; 24(9): 2409-14, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23788753
6.
SEOM clinical guidelines for the treatment of advanced prostate cancer (2020).
Clin Transl Oncol
; 23(5): 969-979, 2021 May.
Artigo
Inglês
| MEDLINE | ID: mdl-33625671
7.
Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM).
ESMO Open
; 6(2): 100048, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33556897
8.
SEOM clinical guideline for treatment of kidney cancer (2019).
Clin Transl Oncol
; 22(2): 256-269, 2020 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-31993962
9.
SEOM clinical guidelines in hereditary breast and ovarian cancer (2019).
Clin Transl Oncol
; 22(2): 193-200, 2020 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-31889241
10.
Latest progress in molecular biology and treatment in genitourinary tumours.
Clin Transl Oncol
; 22(12): 2175-2195, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-32440915
11.
Correction to: SEOM clinical guideline for treatment of kidney cancer (2017).
Clin Transl Oncol
; 21(5): 692-693, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30798511
12.
Correction to: SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).
Clin Transl Oncol
; 21(6): 817, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30806902
13.
SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018).
Clin Transl Oncol
; 21(1): 64-74, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30565086
14.
SEOM clinical guideline for treatment of kidney cancer (2017).
Clin Transl Oncol
; 20(1): 47-56, 2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-29134564
15.
SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).
Clin Transl Oncol
; 18(12): 1197-1205, 2016 12.
Artigo
Inglês
| MEDLINE | ID: mdl-27900539
16.
SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)
Clin. transl. oncol. (Print)
; 23(5): 969-979, mayo 2021. tab
Artigo
Inglês
| IBECS (Espanha) | ID: ibc-221237
17.
2019 SEOM guidelines (the end of a decade).
Clin Transl Oncol
; 22(2): 169-170, 2020 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-32030655
18.
SEOM clinical guidelines for the treatment of metastatic prostate cancer.
Clin Transl Oncol
; 16(12): 1060-6, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25319721
19.
SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018)
Clin. transl. oncol. (Print)
; 21(1): 64-74, ene. 2019. tab
Artigo
Inglês
| IBECS (Espanha) | ID: ibc-183345
20.
SEOM clinical guideline for treatment of kidney cancer (2017)
Clin. transl. oncol. (Print)
; 20(1): 47-56, ene. 2018. tab
Artigo
Inglês
| IBECS (Espanha) | ID: ibc-170467